Download - France Groupe Welcoop
![Page 1: France Groupe Welcoop](https://reader036.vdocument.in/reader036/viewer/2022083119/54c061f24a795989618b45f7/html5/thumbnails/1.jpg)
COOPERATIVES WORKING IN THE PHARMACY
SECTOR
FRANCE
RomeMarch 31st 2009
![Page 2: France Groupe Welcoop](https://reader036.vdocument.in/reader036/viewer/2022083119/54c061f24a795989618b45f7/html5/thumbnails/2.jpg)
1. Distribution & Pharmacies suffer from market pressure
• Price structure on reimbursed medicines for France1999 2007
State 5,9% 6.6%Manufacturer 64.2% 67.6%Wholesale 3.8% 2.5%Pharmacies 26.1% 23.3%
Wholesalers are suffering most
KEY FIGURES & FACT
![Page 3: France Groupe Welcoop](https://reader036.vdocument.in/reader036/viewer/2022083119/54c061f24a795989618b45f7/html5/thumbnails/3.jpg)
2. Direct sales to pharmacy by manufacturers on reimbursed medicines
2001 = 8,3%2006 = 15%Estimated 2012 = 19,5%
France is N°1 for direct sales in Europe
KEY FIGURES & FACT
![Page 4: France Groupe Welcoop](https://reader036.vdocument.in/reader036/viewer/2022083119/54c061f24a795989618b45f7/html5/thumbnails/4.jpg)
3. Generic market2008 = 10% value and 20% volume
57% of the distribution is done by direct sales, not by full line wholesalers 1 900
2 200
1 082
750
480
292
74197
1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
13941500
Turnover in Millions €
KEY FIGURES & FACT
![Page 5: France Groupe Welcoop](https://reader036.vdocument.in/reader036/viewer/2022083119/54c061f24a795989618b45f7/html5/thumbnails/5.jpg)
4. New risks emerged in France
Opening of the capital of pharmaciesDTP model (as in the UK)Double pricingQuota system
=> A new economic model is being modelled towards the development of servicesservices to pharmacies
KEY FIGURES & FACT
![Page 6: France Groupe Welcoop](https://reader036.vdocument.in/reader036/viewer/2022083119/54c061f24a795989618b45f7/html5/thumbnails/6.jpg)
Strategies of cooperatives in France become clearer:
- consolidation of wholesale activities at European level (Millenium)
- wholesale competition at national level in areas where historically cooperatives were lonely (Cerp Rouen, Cerp Rhin Rhône Méditerranée)
- connections with Group of pharmacies (CERPenthès)
- disengagement of the historic wholesale business activity (Cerp Lorraine sold to Phoenix Pharma)
- introduction of a new economic model (Groupe Welcoop)
![Page 7: France Groupe Welcoop](https://reader036.vdocument.in/reader036/viewer/2022083119/54c061f24a795989618b45f7/html5/thumbnails/7.jpg)
Groupe WELCOOP (ex Cerp Lorraine Group) proposes to the 22,600 pharmacies of France to become owner of their suppliers.
WELCOOP :THE NEW ECONOMIC MODEL
![Page 8: France Groupe Welcoop](https://reader036.vdocument.in/reader036/viewer/2022083119/54c061f24a795989618b45f7/html5/thumbnails/8.jpg)
This new economic model is based on3 major grounds:
1. Computing and Management with Pharmagest Interactive, leader in France with 43% market share equipping 9.800 pharmacies in France with a complete back-office solution
2. Advice and Organization with Profidia (merchandising, pricing structure, geomarketing…)
3. Products Offer with Generics (Cristers), Medical Equipment (D,Médica) and Parallel Imports (Pharma Lab)
![Page 9: France Groupe Welcoop](https://reader036.vdocument.in/reader036/viewer/2022083119/54c061f24a795989618b45f7/html5/thumbnails/9.jpg)
This new economic model adds a two-way value for the pharmacists:
- increasing the margins with the right to get cooperative dividends based on a percentage on all purchases done with the Products Offer (20% for Cristers, 4% for D,Médica, 5% for Pharma Lab),
- accessing the capital of the Group by opening the capital of the holding Welcoop Pharma
![Page 10: France Groupe Welcoop](https://reader036.vdocument.in/reader036/viewer/2022083119/54c061f24a795989618b45f7/html5/thumbnails/10.jpg)
Future priorities and strategies for French cooperatives :
Find the model of tomorrow to allow the pharmaciststo remain competitive, liberal and independent.
![Page 11: France Groupe Welcoop](https://reader036.vdocument.in/reader036/viewer/2022083119/54c061f24a795989618b45f7/html5/thumbnails/11.jpg)
Thank you for your attention !